PetIQ Inc logo

PetIQ Inc (PETQ)

Delisted
25 Oct 2024
NASDAQ (NGS) NASDAQ (NGS)
$
30. 98
0
0%
$
479.14M Market Cap
41.7 P/E Ratio
- Div Yield
0 Volume
1.07 Eps
$ 30.98
Previous Close
Day Range
30.98 30.98
Year Range
15.09 31.06
Want to track PETQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

PETQ Chart

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS

NEW YORK, NY / ACCESSWIRE / October 9, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

Accesswire | 1 year ago
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS

NEW YORK, NY / ACCESSWIRE / October 8, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (NASDAQ: PETQ ), relating to its proposed merger with Bansk Group.

Accesswire | 1 year ago
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS

STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS

NEW YORK, NY / ACCESSWIRE / October 7, 2024 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: PetIQ, Inc. (Nasdaq: PETQ ), relating to its proposed merger with Bansk Group.

Accesswire | 1 year ago

PetIQ Inc (PETQ) FAQ

What does "Delisted" mean?

PetIQ Inc has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

No dividend payments were recorded prior to delisting.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

No stock splits were recorded prior to delisting.

What was the last known trading price?

The stock last traded at $30.98 on Oct 25, 2024 before being delisted.

PetIQ Inc Profile

- Industry
- Sector
Mr. McCord Christensen CEO
NASDAQ (NGS) Exchange
71639T106 CUSIP
US Country
1,121 Employees
- Last Dividend
- Last Split
21 Jul 2017 IPO Date

Overview

PetIQ, Inc. operates as a comprehensive pet medication and wellness company, serving the needs of pets and their owners across the United States and internationally. Since its inception in 2010, with headquarters in Eagle, Idaho, PetIQ, Inc. has grown into a multi-faceted enterprise. It functions through two main segments, Products and Services, providing an extensive range of pet healthcare solutions. The company is dedicated to improving the well-being of pets by offering affordable and accessible veterinary care and wellness products. By operating through veterinarian, retail, and e-commerce channels, PetIQ, Inc. has established a significant footprint in the pet health industry.

Products and Services

  • Rx Pet Medications:

    PetIQ offers a broad selection of prescription medications for pets, including treatments for flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes, pain, antibiotics, and other specialty medications. These products are vital for pet owners looking to maintain the health and happiness of their pets with pharmaceutical care.

  • Value-Branded and Third-Party Branded Products:

    The company not only develops and manufactures its proprietary value-branded products but also provides third-party branded products for dogs and cats. This includes a mix of medically necessary and wellness products, ensuring a comprehensive range of options for pet health and care.

  • OTC Medications and Supplies:

    Over-the-counter (OTC) medications and supplies offered by PetIQ cover a wide spectrum, including flea and tick control, dog dewormers, and behavior management solutions. These products come in various forms such as spot-on treatments, chewables, oral tablets, and collars, catering to the diverse needs of pet owners for non-prescription care solutions.

  • Health and Wellness Products:

    Under brands like PetArmor®, Rocco & Roxie®, VetIQ®, Minties®, and Sentry®, PetIQ provides health and wellness products including dog and cat treats, oral health solutions, stain and odor treatments, and nutritional supplements. These products are essential for maintaining the general well-being, nutritional health, and hygiene of pets.

  • Veterinarian Service Platform:

    PetIQ operates a veterinarian service platform that offers cost-effective and convenient veterinary wellness services through community clinics, pop-up locations, wellness centers, and permanent locations. Services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks, facilitating comprehensive veterinary care for pets.

Contact Information

Address: 230 East Riverside Drive, Eagle, ID, United States, 83616
Phone: 208 939 8900